Background: Alcohol use typically begins during adolescence and escalates into young adulthood. This represents an important period for the establishment of alcohol use and misuse patterns, which can have psychosocial and medical consequences. Although changes in alcohol use during this time have been phenotypically characterized, their genetic nature is poorly understood.
A LCOHOL USE FREQUENTLY begins in adolescence, with upward of 50% of U.S. 10th graders (Johnston et al., 2013) and over 40% of U.K. 11-to 15-yearolds (Lifestyle Statistics HSCIC, 2014) reporting initiation of alcohol use. Consumption typically increases into young adulthood before stabilizing or tapering off (Johnston et al., 2013) . The pattern of use established during adolescence into young adulthood can be predictive of later alcohol use problems (Blozis et al., 2007; Duncan et al., 1997; Nixon and McClain, 2010) , which are associated with a host of social, economic, and medical costs (McCambridge et al., 2011; Sacks et al., 2015 ; Secretary of State for the Home Department, 2012a,b) . Thus, clarifying the etiology of alcohol misuse has significant implications for public health.
Genetic factors are known to substantially impact alcohol use phenotypes. A recent meta-analysis of twin and adoption studies reported a heritability estimate of 0.49 for alcohol use disorders (Verhulst et al., 2015) . Other studies have reported heritabilities of 0.21 to 0.55 for associated phenotypes such as frequency of use, intoxication frequency, and problem drinking (Derks et al., 2014; Edwards et al., 2011a,b; Geels et al., 2012; Sartor et al., 2013; Wu et al., 2014) . Furthermore, evidence suggests that the heritability of alcohol use phenotypes increases from early adolescence into young adulthood (Bergen et al., 2007) .
Most prior studies investigating the genetic etiology of alcohol outcomes have focused on either cross-sectional data or lifetime measures. However, abundant evidence suggests that alcohol-related behaviors develop over time and vary across individuals (Casswell et al., 2002; Duncan et al., 1997; Tucker et al., 2003; Wiesner et al., 2007; Windle et al., 2005) . Cross-sectional or collapsed (i.e., lifetime) measures fail to capture the dynamic nature of change in alcohol use across time; consequently, genetic studies employing these measures are limited in the extent to which they identify variants or genes that impact the course of alcohol use. Given the complex nature of alcohol use phenotypes, complementary genetic analyses will likely be needed to comprehensively dissect their etiology: Distinct or only partially overlapping genetic factors might impact different aspects such as alcohol use initiation, acceleration of use, alcohol use disorder, recovery, and persistence.
While phenotypic analyses of alcohol use/misuse trajectories are common, corresponding genetic analyses are not. To our knowledge, only 1 prior study has examined genetic influences underlying changes in alcohol outcomes over time. In a study involving 3 U.S. cohorts longitudinally assessed from childhood into young adulthood, Adkins and colleagues (2015) modeled developmental trajectories of alcohol consumption, followed by genomewide association analysis of the resulting slope parameter. Results were meta-analyzed across cohorts, and while no marker met genomewide significance criteria for association with the slope, biologically plausible suggestive markers were identified, and secondary analyses implicated genes involved in axon guidance and development. Parallel to the analysis of the slope, Adkins and colleagues (2015) conducted association tests for mean alcohol consumption across time. Importantly, distinct genetic loci and pathways were implicated across phenotypes, indicating that the genetic factors impacting changes in alcohol consumption differ from those impacting a measure that is effectively cross-sectional.
This study aims to address the deficit in our understanding of genetic influences on the course of alcohol misuse. We employ data from the Avon Longitudinal Study of Parents and Children (ALSPAC), a prospectively assessed cohort study in the southwest United Kingdom, to quantify growth in alcohol misuse from adolescence to emerging adulthood. As only 1 prior study has subjected a comparable outcome to genetic analysis (Adkins et al., 2015) , this study represents a relatively novel approach to conceptualizing the genetic risk of alcohol use problems.
MATERIALS AND METHODS

Sample
ALSPAC is a cohort-based sample recruited in southwest England. ALSPAC recruited 14,541 pregnant women resident in Avon, UK, with expected dates of delivery April 1, 1991 , to December 31, 1992 14,541 is the initial number of pregnancies for which the mothers enrolled in the ALSPAC study and had either returned at least 1 questionnaire or attended a "Children in Focus" clinic by July 19, 1999. Of these initial pregnancies, there was a total of 14,676 fetuses, resulting in 14,062 live births and 13,988 children who were alive at 1 year of age. Subsequent phases of enrollment increased the sample size over time. The phases of enrollment are described in more detail elsewhere Fraser et al., 2013) . For the current analyses, full or partial phenotypic data were available for 4,545 participants (see below). The study website contains details of all the data that is available through a fully searchable data dictionary (http://www.bris.ac.uk/alspac/ researchers/data-access/data-dictionary/). Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees.
Measures
Participants completed the 10 items of the Alcohol Use Disorders Identification Test (AUDIT; Babor and Grant, 1989) at approximately ages 16.5, 17.5, 18.75, and 20.75 . At age 17.5, data were collected at a clinic, at which participants completed the AUDIT on a computer. Otherwise, data were collected via postal or online questionnaire. Scores for each AUDIT item range from 0 to 4 as a function of how frequently (e.g., "never" to "daily or almost daily") the respondent has experienced that item. Total scores could range from 0 to 40.
Genotyping
Samples were genotyped on the Illumina HumanHap550 quad single nucleotide polymorphism (SNP) genotyping platform by the Wellcome Trust Sanger Institute (Cambridge, UK) and Laboratory Corporation of America (Burlington, NC). Individuals were excluded on the basis of gender mismatch; minimal or excessive heterozygosity; individual missingness >3%; and insufficient sample replication (identical by descent [IBD] < 0.8). Population stratification was assessed using multidimensional scaling analysis and compared to Hapmap II populations; individuals not of European ancestry were excluded. Markers with minor allele frequency (MAF) < 1%, call rate < 95%, and violations of Hardy-Weinberg equilibrium (p < 5e-7) were removed. Individuals with evidence of cryptic relatedness were removed (IBD > 0.1). After quality control filters were applied, data were available for 9,048 subjects and 526,688 SNPs. Haplotypes were estimated using ShapeIT (v2.r644; Oxford, UK), and imputation was conducted using a phased version of the 1000 Genomes reference panel (Phase 1, version 3), using Impute V2.2.2 (Oxford, UK) and all reference haplotypes to maximize imputation quality.
Statistical Analyses
Growth Model. In Mplus version 7.11, we fit a latent growth model (Muth en and Muth en, 2012) for the 4 waves of AUDIT scores. We estimated an intercept (I), slope (S), quadratic (Q), and cubic (C) term, and conducted a series of tests to identify the most parsimonious model that provided a good fit to the data, using root mean square error of approximation (RMSEA), the Tucker-Lewis Index (TLI), and Comparative Fit Index (CFI) to interpret fit.
Genetic Analyses. We conducted a genomewide association study (GWAS) on the imputed (dosage) genetic data using PLINK v1.07 (Purcell et al., 2007) . Only autosomal markers were analyzed. We included sex and 10 ancestry-informative principal components as covariates. Slope was the focal phenotype; other relevant growth factors (I and Q, see Results) were included as covariates.
We used VEGAS2 (Mishra and Macgregor, 2015) to perform gene-based analyses. Such tests represent a biology-based approach to interpreting marker-level results, as they consider aggregate effects across a functionally meaningful genomic region. VEGAS2 mapped markers falling within 50 kb to known genes; this flanking region was selected to capture potentially influential regulatory regions. VEGAS2 accounts for linkage disequilibrium among markers mapping to a given gene based on the selected 1000 Genomes (The 1000 Genomes Project Consortium et al., 2012) reference population (in this case, the European subset). We considered both VEGAS2's gene-based p-values and Benjamini-Hochberg false discovery rates; the latter were derived using p.adjust in R version 3.2.3.
We used genomewide complex trait analysis (GCTA; Yang et al., 2011) to calculate the proportion of phenotypic variance attributable to genetic variation (h 2 SNP ), using only observed variants. The genetic relationship matrix was constructed using a relatedness cutoff of 0.025. We included sex, nonfocal growth parameters, and 10 ancestry-informative principal components as covariates.
Replication. We selected promising (p < 0.0001) markers for individual SNP-based replication attempts using the only available published study of a similar phenotype (Adkins et al., 2015) . pValues were combined across this study and the meta-analytic results from Adkins and colleagues (2015) , using Fisher's method. In addition, we conducted sign tests, using a subset of markers: Markers were first selected for their availability in the replication sample; redundant markers were removed, and reference alleles were aligned across the current results and the replication sample. Because the replication sample was a meta-analysis, combined t-statistics were used rather than betas. Markers were next selected for independence using PLINK-clump option in 2 stages: First, we applied a linkage disequilibrium threshold of r 2 = 0.5 within a 250 kb window; we then applied a threshold of r 2 = 0.2 within a 5 mb window. Selected markers were binned by p-value for sign tests.
Epigenomic Annotations. SNPs were annotated for various epigenetic and functional features using data obtained from HaploReg (v4.1) (Ward and Kellis, 2016) . These data included DNaseI hypersensitive sites (DHS), histone modification sites, and chromatin state segmentations (15-state) produced by the RoadMap Epigenomics Project for various cell types and biological samples (Roadmap Epigenomics et al., 2015) . For each of these cell type-specific features, we calculated the frequencies with which they overlapped any of the assayed SNPs. We then compared the overlap among SNPs nominally associated with growth in alcohol misuse to the background frequencies in order to calculate a cell type-specific fold enrichment score. The background for this analysis comprised a set of 8,887,107 markers, which represents the overlap of markers assayed in this study and included in dbSNP release b137. Enrichment relative to this background was calculated using a binomial statistic. Within each class, we limited our assessment to featurethreshold combinations to which at least 3 markers mapped.
RESULTS
Descriptive Statistics
Individuals who did not endorse alcohol use initiation are coded as missing as they did not satisfy the screening condition for administration of the AUDIT items. A total of 1,332 individuals participated in all 4 waves; N = 1,681 participated in 3 waves; N = 1,532 participated in 2 waves; and N = 2,026 participated in only 1 wave. AUDIT scores at each wave of data collection are provided in Table 1 ; scores increased gradually across time.
Growth Model Fitting
We fit a model based on the AUDIT scores across 4 waves, specifying within Mplus the average temporal lag between waves of data collection. We began with a multigroup model where males were group 1 and females were group 2; we estimated intercept (I), slope (S), quadratic (Q), and cubic (C) terms. The variance of C was constrained to 0 to facilitate model convergence; in addition, within sex, the residual variances of the AUDIT scores were constrained to be equal across waves (Grimm and Widaman, 2010) . The model provided an excellent fit to the data (CFI = 1.000, TLI = 0.999, RMSEA = 0.012). We next assessed sex differences by testing whether the means of I, S, Q, and C differed across sexes and found that they did not (p > 0.1); this model also provided an excellent fit (CFI = 0.998, TLI = 0.998, RMSEA = 0.017). Therefore, subsequent models combined the sexes. We next restricted the model to individuals for whom at least 2 AUDIT scores were available (N = 4,545) (CFI = 0.995, TLI = 0.991, RMSEA = 0.029). Within this sample, we tested models that dropped the C and/or Q growth parameters or restricted Q variance to 0, all of which resulted in a decrement in fit (e.g., RMSEA > 0.05, CFI/TLI < 0.99). Therefore, we selected the model with all 4 growth parameters, with C variance constrained to 0, as our final model. Individual scores on each parameter were exported for use in the subsequent GWAS.
Genomewide Association Analysis
We used the slope term (Grimm et al., 2013 ) from the growth model as the focal phenotype in a GWAS. Of the 4,545 individuals with phenotypic data, genotypic data were available for N = 3,380 individuals. After restricting to markers with INFO ≥ 0.50 and MAF ≥ 0.01, results were available for 8,972,921 markers. There was no evidence of inflation (k = 1.01, SE = 1.11e-6). No marker met genomewide significance criteria (p < 5e-8). The top marker, rs143795029, is located on chromosome 2p12 in an intronic region of LRRTM4 (leucine-rich repeat transmembrane neuronal 4). However, low MAF (0.01) and local linkage disequilibrium suggest that this association is potentially artifactual. The next marker, rs6506977 (p = 7.88e-7), along with 9 neighboring markers with p < 1e-7, maps to the region 45 kb 3 0 of KLHL14 (kelch-like family member 14) on chromosome 18q12.1 (Fig. 1) . The next most strongly implicated region, with top marker rs17397108, maps to 66 kb 3 0 of LMX1A (LIM homeobox transcription factor 1, alpha) on chromosome 1q24.1.
Gene-Based Analysis
Markers with MAF ≥ 0.01 and INFO ≥ 0.50 were submitted to VEGAS2 for gene-based analysis. These markers mapped to 24,233 defined genes. No gene survived corrected significance criteria (q < 0.05). The top gene was NSMCE3 (NSE3 homolog, SMC5-SMC6 complex component; alias NDNL2; p = 0.000037; q = 0.51), on chromosome 15, which plays a role in chromatin remodeling. The second ranking gene, DHX34 (DEAH box polypeptide 34; p = 0.000105; q = 0.51), maps to chromosome 19 and is involved in RNA regulation (Longman et al., 2013) .
Genomewide Complex Trait Analysis
We used GCTA to investigate whether, in aggregate, common genetic variants account for a significant proportion of the phenotypic variance of the slope term. The h 2 SNP estimate was 0.26 (SE = 0.11, p = 0.009), indicating moderate heritability that differed significantly from 0. Although slope was the primary phenotype of interest, we also computed the heritability of the intercept and quadratic terms, which were h 2 SNP =0.11 (SE = 0.11, p = 0.1) and h 2 SNP = 0 (SE = 0.11, p = 0.5), respectively. We further tested the genetic correlation between I and S (Q was excluded due to its 0 estimate) and obtained an estimate of 0.05 (SE = 0.60, ns).
Replication
We selected markers with p < 0.0001 (a threshold chosen to balance statistical support and sample size) for comparison to results reported by Adkins and colleagues (2015) . Of 9,397 markers selected, target sample results were available for 1,141 due to the use of different imputation reference panels across studies. The Fisher's combined p-values were <0.05 for 1,115 of these markers; however, we observed little support for specific variants across the current study and the 3 component studies of the Adkins and colleagues (2015) meta-analysis (Table S1 ).
We conducted sign tests using independent markers selected for their availability in both the current study and the replication study (N = 465,265). We then binned according to discovery sample p-value and determined the number of markers within each bin with the same direction of effect across studies. Results are provided in Table 2 . At stringent significance thresholds (p ≤ 0.0001), we observed modest evidence of agreement across studies, although these results are based on small numbers of markers. At more inclusive thresholds (p ≤ 0.10 to p ≤ 0.50), results indicated more consistently significant overlap.
Localization of Implicated Markers to Putative Functional Regions
Enrichment analyses were conducted for 3 classes of epigenetic features: (i) chromatin marks, which are subdivided into 15 classes; (ii) DHS; and (iii) histone mark peaks. Table 3 provides the 5 highest enrichment scores for each class; Table S2 provides complete results. For DHS, the top categories included markers with p < 0.00001; the 2 top categories correspond to putatively active genomic regions in 
DISCUSSION
Genetic factors are known to influence alcohol use phenotypes including initiation, frequency of use, and alcohol use disorder. Prior studies have illustrated that there is variation in the development of alcohol use over time, with adolescence into young adulthood comprising a critical period for the establishment of alcohol use patterns that can be predictive of later problems. We demonstrate that growth in alcohol misuse is moderately heritable (h 2 SNP = 0.26), and that genes contributing to growth represent biologically plausible candidate genes. Furthermore, the low co-heritability between initial (age 16.5) alcohol misuse and slope indicates that genetic factors influencing distinct aspects of the development of alcohol misuse are largely, although not entirely, independent. Indeed, risk factors, genetic or otherwise, impacting alcohol misuse may only partially overlap with risk factors for alcohol consumption, initiation, etc. We observed support for implicated variants, in aggregate, in a U.S. replication sample, suggesting that genetic factors influencing changes in alcohol misuse in the United Kingdom are generalizable to an ethnically similar population. Exploratory in silico molecular analyses indicate that implicated variants map to genomic locations transcriptionally active during brain development.
The growth model demonstrates that AUDIT scores increase from age 16.5 through 20.75 in a nonlinear fashion, with the inclusion of both quadratic and cubic terms contributing to model fit. Previous studies of samples in a similar age range have also shown that alcohol use/misuse increases during this period (Casswell et al., 2002; Jackson et al., 2008; Tucker et al., 2003) . Although not all prior studies have included a nonlinear growth term in their longitudinal models, Marmorstein (2009) reported that a quadratic term improved model fit when examining alcohol use-related problems in a large sample of individuals in their adolescence into early adulthood. In that sample, alcohol problems peaked at 22, followed by a gradual decline. Similarly, Walden and colleagues (2007) reported nonlinear growth in alcohol consumption and alcohol dependence symptom counts. We included the quadratic term as a covariate in our analyses (the cubic term was excluded as its variance was fixed to 0), but focused on the slope term as the outcome of interest given its interpretable nature. Future studies may benefit from analysis of genetic influences on the nonlinear components of growth in alcohol misuse, and we note that the current study's focus on the slope represents a limited perspective on genetic influences on change in alcohol misuse. Joint consideration of the growth factors (e.g., a multivariate GWAS) may have had an impact on our results and their interpretation. Walden and colleagues (2007) , using a sample of adolescent twins, found that a parental history of alcohol problems and/or higher parental alcohol consumption predicted greater rates of change in offspring alcohol outcomes. Given that a proportion of the risk conferred by parental problems is genetic, those results are conceptually consistent with the current findings, in that genetic liability contributes to the course of alcohol misuse during this critical developmental period. The heritability estimate of the slope obtained from observed variants is consistent with, although modestly lower than, estimates for other alcohol-related phenotypes. Evidently, and unsurprisingly, environmental factors account for a substantial proportion of risk in course of alcohol problems during this time frame. Such factors might include peer behavior (Barnett et al., 2014; Bertholet et al., 2013) or college attendance (Carter et al., 2010; Slutske, 2005) . Although outside the scope of the current analyses, future studies might assess whether genetic liability for increasing alcohol problems over time is moderated by specific environmental protective or risk factors.
Our findings suggest 2 genes, KLHL14 and LMX1A, warrant further investigation based on SNP-level findings. KLHL14 is expressed in neuronal cell bodies, and the protein interacts with the TOR1A protein (encoded by torsin family 1, member A), which is expressed in the substantia nigra pars compacta, a region that is responsive to ethanol (EtOH) infusion (Asyyed et al., 2006) and EtOH withdrawal (Kozell et al., 2005) in mice. LMX1A, proximal to the set of SNPs nominally implicated (p ≤ 1.19e-6) on chromosome 1, is of potential interest based on its known function: In addition to its role in insulin gene transcription, it is involved in the embryonic development of dopaminergic neurons (DoucetBeaupre et al., 2015) , which are central to the neurobiology of drugs of abuse (Korpi et al., 2015) . In addition, preliminary evidence suggests an association between variation in LMX1A and cognitive functioning and psychiatric disorders (Bergman et al., 2010; Rolstad et al., 2015) . Thus, although these genes have not been directly associated with alcoholrelated outcomes in prior studies, they represent biologically plausible candidates for follow-up. Molecular follow-up of implicated genes and putatively functional polymorphisms is ongoing.
Our attempts at replication using meta-analytic results, which were derived from 3 longitudinally assessed samples of comparable ages (Adkins et al., 2015) , provide additional support for our results and suggest that the current findings are generalizable. Although comparisons of significance of individual markers did not strongly implicate specific loci, sign tests indicate that the direction of effect is consistent across studies more frequently than expected by chance. This was true for markers meeting relatively stringent significance thresholds as well as for markers meeting higher p-value thresholds. This is consistent with the polygenic nature of alcohol use phenotypes: We expect many genetic variants to incrementally impact the trajectory of alcohol use from adolescence into emerging adulthood. We note that the strength of the replication using this method is modest: Only a small number of markers meet the more stringent thresholds, thereby reducing statistical power, and while the large number of markers meeting less stringent thresholds conveys higher power, the proportion of markers with the same direction of effect at those thresholds only slightly exceeds 50%.
We therefore caution against over-interpretation of the sign test results.
Our exploratory enrichment analysis provides insight as to the potential functional role of markers implicated at various p-value thresholds. Results suggest that markers with p < 0.00001 disproportionately map to open chromatin (indicated by DHS or H3K4me1 marks) in brain tissue. Fetal brain tissue is of particular relevance, implying that these markers play a role in central nervous system development. Further analyses are planned to investigate whether genotypes at the implicated loci have potential functional consequences, such as differential expression of proximal genes; in the interim the current findings should be considered preliminary.
Limitations
The refined phenotype limited our ability to attempt replication in other data sets. While the AUDIT does include items related to alcohol consumption, the total score used in the current analyses is designed to capture problems/misuse, and in particular, our analysis of growth in this construct was relatively novel. Although comparable phenotypic analyses (i.e., growth models of alcohol misuse) exist, there is, to our knowledge, only 1 published report of a genetic analysis of the slope of a longitudinally assessed alcohol outcome (Adkins et al., 2015) . We observed inconsistent evidence of replication, with top markers failing to replicate across studies. However, sign tests, which investigate replication at the aggregate level, did provide modest support for common SNP effects across samples. These findings warrant confirmation in additional studies. However, we note that phenotype definition is critical for valid replication attempts: The low (and nonsignificant) coheritability between the intercept and slope terms within the current sample suggests that replication using a more standard phenotype (e.g., a cross-sectional measure of alcohol misuse) would not be informative, as variants would not be expected to impact both measures. Furthermore, this may have impacted the somewhat modest level of replication we observed, as Adkins and colleagues (2015) employed a measure of alcohol consumption rather than problems: There is likely incomplete overlap among the factors-genetic or otherwise-that impact various alcoholrelated outcomes such as problems versus consumption.
The ALSPAC sample is homogenous with respect to ethnicity. While this makes the sample ideal for genetic analysis, it does present limitations with respect to generalizability to other samples. Environmental factors that impact alcohol outcomes differ across cultures; for example, the legal drinking age in the United Kingdom is younger than in the United States, and light alcohol consumption among early adolescents is sanctioned within some cultures but not others. One straightforward consequence of cross-sample comparability is that such environmental influences affect heritability estimates. However, the genetic etiology of alcohol problems is not known to differ substantially across populations, with the important exception of variation within alcohol metabolizing genes being far more common within East Asian populations (Edenberg, 2007) .
Despite these concerns, the results presented herein represent a contribution to emergent evidence that the course of alcohol use phenotypes has a substantial genetic component. While phenotypic studies have long acknowledged the essential developmental aspect of alcohol problems, the application of genetic approaches to this aspect of etiology is relatively nascent. Further clarification of these genetic factors is critical to improving our understanding of how alcohol misuse unfolds during development.
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